# FDA Inspection 556818 - Continental Services Group, Inc. - January 14, 2009

Source: https://www.keypedia.com/records/fda_inspections/continental-services-group-inc/5f0da35e-bb5b-4d15-a12f-711722df2257
Source feed: FDA_Inspections

> FDA Inspection 556818 for Continental Services Group, Inc. on January 14, 2009. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 556818
- Company Name: Continental Services Group, Inc.
- Inspection Date: 2009-01-14
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1314786 - 2026-04-30](https://www.keypedia.com/records/fda_inspections/continental-services-group-inc/55b9157e-b544-42f8-aae3-2c295c2fa1e3)
- [FDA Inspection 1244489 - 2024-07-24](https://www.keypedia.com/records/fda_inspections/continental-services-group-inc/de22fa4f-f934-426b-b70f-b57033fddbc1)
- [FDA Inspection 1178109 - 2022-08-24](https://www.keypedia.com/records/fda_inspections/continental-services-group-inc/baad41ec-56c6-4c14-bf27-2532c0bbe7c8)
- [FDA Inspection 1178109 - 2022-08-24](https://www.keypedia.com/records/fda_inspections/continental-services-group-inc/9c1ad310-1843-43b9-9a3f-da019b9bac42)
- [FDA Inspection 1091317 - 2019-05-31](https://www.keypedia.com/records/fda_inspections/continental-services-group-inc/d8e4a6b0-caa9-4ca8-a313-6264ef49c315)

Company: https://www.keypedia.com/companies/continental-services-group-inc/72358f1d-9b15-4d27-87c5-434e7b5f27d1

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d